Parimal Nathwani

Vasomune Therapeutics, Inc. operates as an early stage biopharmaceutical company. It develops medicines to harness the body’s ability to defend against illness by modifying cellular response to disease. The company is headquartered in Toronto, Canada.

Toronto Innovation operates as a commercialization agent. Its technologies disclosed span therapeutics, medical devices and diagnostic imaging, information and communications technologies, and advanced manufacturing and clean technologies. The company was founded by Raphael Hofstein in June 2009 and is headquartered in Toronto, Canada.

Triphase Accelerator Corp. develops oncology drug therapeutics. It engages in accelerating oncology products from pre-investigational new drug (pre-IND) to Phase I/Phase II POC. The firm?s product includes Marizomib which is used in cancer treatment. The company is headquartered in Toronto, Canada.

Versant Partners, Inc. is a broker/dealer headquartered in Montreal with additional offices in Toronto and Calgary. The firm offers a full array of investment services to institutional money managers and Canadian growth companies. They cover the aerospace, biotechnology, electronics manufacturing, communications equipment and services sectors. Within those sectors, Versant Partners focuses primarily on small- and mid-sized companies. The firm executes trades on all major North American stock exchanges. They are a member of the Canadian Investor Protection Fund.

ScarX Therapeutics, Inc. engages in the provision of biotechnology services. It discovers and develops innovative treatments for dermal scarring. The company was founded by Benjamin Alman in 2012 and is headquartered in Ontario, Canada.